Arkolith/Insider Trading/PHIO/Form 4

Kontulis Caitlin

Secretary & VP Finance & AdminPhio Pharmaceuticals Corp. (PHIO) · full profile →Form 4 · filed Feb 20, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2024Tax withholding(F)523$0.66$34511K
Feb 15, 2024Tax withholding(F)658$0.65$42812K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-24-001086) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Phio Pharmaceuticals Corp.

Build

Ask your agent about PHIO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001683168-24-001086"
Ask your agent
Use Arkolith to summarize insider buying and selling at Phio Pharmaceuticals Corp.
over the last 90 days and cite the filings.